Kangyuan Pharmaceutical: Received the notice of approval for clinical trials of Lianshen menopause granules
Updated on: 11-0-0 0:0:0

Per AI Express, Kangyuan Pharmaceutical announced that the company recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration.

National Business Daily